Older age, HTN, DL, CKD, and PAD may contribute to anemia of chronic disease, potentially offsetting SGLT-2 inhibitor effects and reducing erythrocytosis risk [23]. The gene discussed is SLC5A2; the disease is peripheral arterial disease.